Track the 웰바이오텍 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Retail sector, 웰바이오텍 has logged 52 public disclosures. The latest transaction was disclosed on 27 January 2026 (Purchase). Among the most active insiders: 메타프리즈. All data is openly available.
52
Insider Decl.
n/a
Thresholds
n/a
30 ops.
Buy Volume
n/a
2 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.